TD 360 Videos

In-depth Discussion about Deutetrabenazine and Valbenazine
Drs. Jain and Kumar provide and in-depth analysis of two new VMAT2 inhibitors approved to treat tardive dyskinesia.
Trunk (neck, shoulders, hips)
e.g. rocking, twisting, squirming, pelvic gyrations More Videos
Lower Extremities (legs, knees, ankles, toes)
eg. lateral knee movements, foot tapping, heel dropping, foot squirming, inversion and eversion of foot
Upper Extremities (arms, wrists, hands, fingers)
Upper Extremity Movements include choreic movements (ie, rapid, objectively purposeless, irregular, spontaneous); athetoid movements (ie slow, irregular, complex, serpentine). DO NOT include tremor (ie, repetitive, regular, rhythmic)
Tongue
Rate only increases in movement both in and out of mouth. NOT inability to sustain movement. Darting in and out of mouth.
Jaw
e.g. biting, clenching, chewing, mouth opening, lateral movement More Videos

Abnormal Involuntary Movement Scale (AIMS) Exam

AIMS Exam Instructional Video
Psych Congress co-chair Rakesh Jain, MD, MPH, explains the importance of the Abnormal Involuntary Movement Scale (AIMS) exam in the diagnosis and monitoring of patients with tardive dyskinesia.
In-Depth Scoring Sample Playlists
Comprehensive AIMS Scoring Samples Playlist
From normal (0) to severe (4), see what real tardive dyskinesia movements look like so you can better assess your patients.

Diagnosis Discussion Points

AIMS Exam: Part of Routine Psychiatric Practice?
Drs. Jain and Kumar explain the importance of properly screening for tardive dyskinesia in patients on antipsychotics.
TD Phenotypes: What are they, and how do you manage them?
Drs. Jain and Kumar talk about understanding and differentiating between tardive dyskinesia phenotypes.
Functional Impairment in TD: When to Treat
Drs. Jain and Kumar discuss implications of functional impairment associated with tardive dyskinesia.
Beyond Dyskinesia: Addressing Akathisia, Dystonia, and More
Drs. Jain and Kumar discuss the differences between dyskinesia, akathisia, dystonia, and more.
TD v Drug-induced Parkinsonism
Drs. Jain and Kumar discuss the differences between tardive dyskinesia and drug-induced parkinsonism.

Treatment Discussion Points

In-depth Discussion about Deutetrabenazine and Valbenazine
Drs. Jain and Kumar provide and in-depth analysis of two new VMAT2 inhibitors approved to treat tardive dyskinesia.
In-depth Discussion about Deutetrabenazine and Valbenazine
Drs. Jain and Kumar provide and in-depth analysis of two new VMAT2 inhibitors approved to treat tardive dyskinesia.
What is the goal of VMAT2 treatment?
Drs. Jain and Kumar discuss what clinicians should expect when prescribing a VMAT2 inhibitor.
How long should a patient be on a VMAT2?
Drs. Jain and Kumar review dosing and duration of VMAT2. More Videos
Understanding QTc Warnings and VMAT2 Inhibitors
Drs. Jain and Kumar explain QTc warnings as they relate to VMAT2 inhibitors for the treatment of tardive dyskinesia.
Tips for Managing Side-effects of VMAT2 Inhibitors
Drs. Jain and Kumar review side-effects of deutetrabenazine and valbenazine. More Videos
Practical Tips on Increasing Adherence with VMAT2 Inhibitors
Drs. Jain and Kumar review practical tips to increase adherence to tardive dyskinesia treatment.
Practical Tips for VMAT2 Inhibitor Prescription Approval
Drs. Jain and Kumar provide practical tips to overcome obstacles in VMAT2 inhibitor prescription approval.
Anticholinergics and TD: Should they be prescribed?
Drs. Jain and Kumar discuss anticholinergics as they relate to the treatment of tardive dyskinesia.
Alternative Treatments for TD (non-VMAT2 inhibitors)
Drs. Jain and Kumar review alternative treatments to treat tardive dyskinesia. More Videos

Miscellaneous

Strengthening the Connection between Psychiatry and Neurology
Dr. Rakesh Jain (a psychiatrist) and Dr. Rajeev Kumar (a neurologist) discuss the importance of collaboration between psychiatry and neurology, particularly as it relates to tardive dyskinesia diagnosis and treatment.
The Patient Perspective
Listen to a variety of patients talk about how tardive dyskinesia has impacted their daily life.
A Double Life: A Psychotherapist Reflects on Life with Tardive Dyskinesia
Drs. Jain and Kumar interview Karen, a psychotherapist who retired from practice in December 2017 after struggling to cope with her tardive dyskinesia and akathisia.
Before and After Treatment
See first-hand the impact VMAT2 inhibitors have on improving patient symptoms and quality of life after just 24 hours on medication.
New Strategies for Treating Tardive Dyskinesia
Joseph P. McEvoy, MD, discusses new strategies for treating tardive dyskinesia. Dr. McEvoy is Professor of Psychiatry and Health Behavior and the I. Clark Case Chair in Psychotic Disorders at the Medical College of Georgia.
Back to Top